1 Study Coverage 1.1 Dexmedetomidine Hydrochloride for Injection Product Introduction 1.2 Market by Type 1.2.1 Global Dexmedetomidine Hydrochloride for Injection Market Size Growth Rate by Type 1.2.2 100mcg/ml 1.2.3 200mcg/2ml 1.3 Market by Application 1.3.1 Global Dexmedetomidine Hydrochloride for Injection Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Clinics 1.3.4 Recovery Center 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Dexmedetomidine Hydrochloride for Injection Market Size, Estimates and Forecasts 2.1.1 Global Dexmedetomidine Hydrochloride for Injection Revenue 2016-2027 2.1.2 Global Dexmedetomidine Hydrochloride for Injection Sales 2016-2027 2.2 Global Dexmedetomidine Hydrochloride for Injection, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Dexmedetomidine Hydrochloride for Injection Historical Market Size by Region (2016-2021) 2.3.1 Global Dexmedetomidine Hydrochloride for Injection Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Dexmedetomidine Hydrochloride for Injection Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Dexmedetomidine Hydrochloride for Injection Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Dexmedetomidine Hydrochloride for Injection Sales Forecast by Region (2022-2027) 2.4.2 Global Dexmedetomidine Hydrochloride for Injection Revenue Forecast by Region (2022-2027) 3 Global Dexmedetomidine Hydrochloride for Injection Competitor Landscape by Players 3.1 Global Top Dexmedetomidine Hydrochloride for Injection Manufacturers by Sales 3.1.1 Global Dexmedetomidine Hydrochloride for Injection Sales by Manufacturer (2016-2021) 3.1.2 Global Dexmedetomidine Hydrochloride for Injection Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Dexmedetomidine Hydrochloride for Injection Manufacturers by Revenue 3.2.1 Key Dexmedetomidine Hydrochloride for Injection Manufacturers Covered: Ranking by Revenue 3.2.2 Global Dexmedetomidine Hydrochloride for Injection Revenue by Manufacturers (2016-2021) 3.2.3 Global Dexmedetomidine Hydrochloride for Injection Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Dexmedetomidine Hydrochloride for Injection Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Dexmedetomidine Hydrochloride for Injection Revenue in 2020 3.2.6 Global Dexmedetomidine Hydrochloride for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Dexmedetomidine Hydrochloride for Injection Price by Manufacturers 3.4 Global Dexmedetomidine Hydrochloride for Injection Manufacturing Base Distribution, Product Types 3.4.1 Dexmedetomidine Hydrochloride for Injection Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Dexmedetomidine Hydrochloride for Injection Product Type 3.4.3 Date of International Manufacturers Enter into Dexmedetomidine Hydrochloride for Injection Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Dexmedetomidine Hydrochloride for Injection Market Size by Type (2016-2021) 4.1.1 Global Dexmedetomidine Hydrochloride for Injection Sales by Type (2016-2021) 4.1.2 Global Dexmedetomidine Hydrochloride for Injection Revenue by Type (2016-2021) 4.1.3 Dexmedetomidine Hydrochloride for Injection Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Dexmedetomidine Hydrochloride for Injection Market Size Forecast by Type (2022-2027) 4.2.1 Global Dexmedetomidine Hydrochloride for Injection Sales Forecast by Type (2022-2027) 4.2.2 Global Dexmedetomidine Hydrochloride for Injection Revenue Forecast by Type (2022-2027) 4.2.3 Dexmedetomidine Hydrochloride for Injection Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Dexmedetomidine Hydrochloride for Injection Market Size by Application (2016-2021) 5.1.1 Global Dexmedetomidine Hydrochloride for Injection Sales by Application (2016-2021) 5.1.2 Global Dexmedetomidine Hydrochloride for Injection Revenue by Application (2016-2021) 5.1.3 Dexmedetomidine Hydrochloride for Injection Price by Application (2016-2021) 5.2 Dexmedetomidine Hydrochloride for Injection Market Size Forecast by Application (2022-2027) 5.2.1 Global Dexmedetomidine Hydrochloride for Injection Sales Forecast by Application (2022-2027) 5.2.2 Global Dexmedetomidine Hydrochloride for Injection Revenue Forecast by Application (2022-2027) 5.2.3 Global Dexmedetomidine Hydrochloride for Injection Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Dexmedetomidine Hydrochloride for Injection Market Size YoY Growth 2016-2027 6.1.1 China Dexmedetomidine Hydrochloride for Injection Sales YoY Growth 2016-2027 6.1.2 China Dexmedetomidine Hydrochloride for Injection Revenue YoY Growth 2016-2027 6.1.3 China Dexmedetomidine Hydrochloride for Injection Market Share in Global Market 2016-2027 6.2 China Dexmedetomidine Hydrochloride for Injection Market Size by Players (International and Local Players) 6.2.1 China Top Dexmedetomidine Hydrochloride for Injection Players by Sales (2016-2021) 6.2.2 China Top Dexmedetomidine Hydrochloride for Injection Players by Revenue (2016-2021) 6.3 China Dexmedetomidine Hydrochloride for Injection Historic Market Review by Type (2016-2021) 6.3.1 China Dexmedetomidine Hydrochloride for Injection Sales Market Share by Type (2016-2021) 6.3.2 China Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Type (2016-2021) 6.3.3 China Dexmedetomidine Hydrochloride for Injection Price by Type (2016-2021) 6.4 China Dexmedetomidine Hydrochloride for Injection Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Dexmedetomidine Hydrochloride for Injection Sales Forecast by Type (2022-2027) 6.4.2 China Dexmedetomidine Hydrochloride for Injection Revenue Forecast by Type (2022-2027) 6.4.3 China Dexmedetomidine Hydrochloride for Injection Price Forecast by Type (2022-2027) 6.5 China Dexmedetomidine Hydrochloride for Injection Historic Market Review by Application (2016-2021) 6.5.1 China Dexmedetomidine Hydrochloride for Injection Sales Market Share by Application (2016-2021) 6.5.2 China Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Application (2016-2021) 6.5.3 China Dexmedetomidine Hydrochloride for Injection Price by Application (2016-2021) 6.6 China Dexmedetomidine Hydrochloride for Injection Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Dexmedetomidine Hydrochloride for Injection Sales Forecast by Application (2022-2027) 6.6.2 China Dexmedetomidine Hydrochloride for Injection Revenue Forecast by Application (2022-2027) 6.6.3 China Dexmedetomidine Hydrochloride for Injection Price Forecast by Application (2022-2027) 7 North America 7.1 North America Dexmedetomidine Hydrochloride for Injection Market Size YoY Growth 2016-2027 7.2 North America Dexmedetomidine Hydrochloride for Injection Market Facts & Figures by Country 7.2.1 North America Dexmedetomidine Hydrochloride for Injection Sales by Country (2016-2021) 7.2.2 North America Dexmedetomidine Hydrochloride for Injection Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Dexmedetomidine Hydrochloride for Injection Market Size YoY Growth 2016-2027 8.2 Asia Pacific Dexmedetomidine Hydrochloride for Injection Market Facts & Figures by Region 8.2.1 Asia Pacific Dexmedetomidine Hydrochloride for Injection Sales by Region (2016-2021) 8.2.2 Asia Pacific Dexmedetomidine Hydrochloride for Injection Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Dexmedetomidine Hydrochloride for Injection Market Size YoY Growth 2016-2027 9.2 Europe Dexmedetomidine Hydrochloride for Injection Market Facts & Figures by Country 9.2.1 Europe Dexmedetomidine Hydrochloride for Injection Sales by Country (2016-2021) 9.2.2 Europe Dexmedetomidine Hydrochloride for Injection Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Dexmedetomidine Hydrochloride for Injection Market Size YoY Growth 2016-2027 10.2 Latin America Dexmedetomidine Hydrochloride for Injection Market Facts & Figures by Country 10.2.1 Latin America Dexmedetomidine Hydrochloride for Injection Sales by Country (2016-2021) 10.2.2 Latin America Dexmedetomidine Hydrochloride for Injection Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Dexmedetomidine Hydrochloride for Injection Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Dexmedetomidine Hydrochloride for Injection Market Facts & Figures by Country 11.2.1 Middle East and Africa Dexmedetomidine Hydrochloride for Injection Sales by Country (2016-2021) 11.2.2 Middle East and Africa Dexmedetomidine Hydrochloride for Injection Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Pfizer 12.1.1 Pfizer Corporation Information 12.1.2 Pfizer Description and Business Overview 12.1.3 Pfizer Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Pfizer Dexmedetomidine Hydrochloride for Injection Products Offered 12.1.5 Pfizer Recent Development 12.2 Accord Healthcare 12.2.1 Accord Healthcare Corporation Information 12.2.2 Accord Healthcare Description and Business Overview 12.2.3 Accord Healthcare Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Accord Healthcare Dexmedetomidine Hydrochloride for Injection Products Offered 12.2.5 Accord Healthcare Recent Development 12.3 Akorn 12.3.1 Akorn Corporation Information 12.3.2 Akorn Description and Business Overview 12.3.3 Akorn Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Akorn Dexmedetomidine Hydrochloride for Injection Products Offered 12.3.5 Akorn Recent Development 12.4 AuroMedics 12.4.1 AuroMedics Corporation Information 12.4.2 AuroMedics Description and Business Overview 12.4.3 AuroMedics Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.4.4 AuroMedics Dexmedetomidine Hydrochloride for Injection Products Offered 12.4.5 AuroMedics Recent Development 12.5 Fresenius Kabi 12.5.1 Fresenius Kabi Corporation Information 12.5.2 Fresenius Kabi Description and Business Overview 12.5.3 Fresenius Kabi Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Fresenius Kabi Dexmedetomidine Hydrochloride for Injection Products Offered 12.5.5 Fresenius Kabi Recent Development 12.6 Hikma 12.6.1 Hikma Corporation Information 12.6.2 Hikma Description and Business Overview 12.6.3 Hikma Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Hikma Dexmedetomidine Hydrochloride for Injection Products Offered 12.6.5 Hikma Recent Development 12.7 Mylan 12.7.1 Mylan Corporation Information 12.7.2 Mylan Description and Business Overview 12.7.3 Mylan Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Mylan Dexmedetomidine Hydrochloride for Injection Products Offered 12.7.5 Mylan Recent Development 12.8 Par Pharmaceuticals 12.8.1 Par Pharmaceuticals Corporation Information 12.8.2 Par Pharmaceuticals Description and Business Overview 12.8.3 Par Pharmaceuticals Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Par Pharmaceuticals Dexmedetomidine Hydrochloride for Injection Products Offered 12.8.5 Par Pharmaceuticals Recent Development 12.9 Sandoz 12.9.1 Sandoz Corporation Information 12.9.2 Sandoz Description and Business Overview 12.9.3 Sandoz Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Sandoz Dexmedetomidine Hydrochloride for Injection Products Offered 12.9.5 Sandoz Recent Development 12.10 Sun Pharma 12.10.1 Sun Pharma Corporation Information 12.10.2 Sun Pharma Description and Business Overview 12.10.3 Sun Pharma Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Sun Pharma Dexmedetomidine Hydrochloride for Injection Products Offered 12.10.5 Sun Pharma Recent Development 12.11 Pfizer 12.11.1 Pfizer Corporation Information 12.11.2 Pfizer Description and Business Overview 12.11.3 Pfizer Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Pfizer Dexmedetomidine Hydrochloride for Injection Products Offered 12.11.5 Pfizer Recent Development 12.12 Athenex 12.12.1 Athenex Corporation Information 12.12.2 Athenex Description and Business Overview 12.12.3 Athenex Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Athenex Products Offered 12.12.5 Athenex Recent Development 12.13 Cisen Pharmaceutical 12.13.1 Cisen Pharmaceutical Corporation Information 12.13.2 Cisen Pharmaceutical Description and Business Overview 12.13.3 Cisen Pharmaceutical Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Cisen Pharmaceutical Products Offered 12.13.5 Cisen Pharmaceutical Recent Development 12.14 Jiangsu Hengrui Pharm 12.14.1 Jiangsu Hengrui Pharm Corporation Information 12.14.2 Jiangsu Hengrui Pharm Description and Business Overview 12.14.3 Jiangsu Hengrui Pharm Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Jiangsu Hengrui Pharm Products Offered 12.14.5 Jiangsu Hengrui Pharm Recent Development 12.15 Hunan Kelun Pharmaceutical 12.15.1 Hunan Kelun Pharmaceutical Corporation Information 12.15.2 Hunan Kelun Pharmaceutical Description and Business Overview 12.15.3 Hunan Kelun Pharmaceutical Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Hunan Kelun Pharmaceutical Products Offered 12.15.5 Hunan Kelun Pharmaceutical Recent Development 12.16 Curegen Pharmaceutical 12.16.1 Curegen Pharmaceutical Corporation Information 12.16.2 Curegen Pharmaceutical Description and Business Overview 12.16.3 Curegen Pharmaceutical Dexmedetomidine Hydrochloride for Injection Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Curegen Pharmaceutical Products Offered 12.16.5 Curegen Pharmaceutical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Dexmedetomidine Hydrochloride for Injection Industry Trends 13.2 Dexmedetomidine Hydrochloride for Injection Market Drivers 13.3 Dexmedetomidine Hydrochloride for Injection Market Challenges 13.4 Dexmedetomidine Hydrochloride for Injection Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Dexmedetomidine Hydrochloride for Injection Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Dexmedetomidine Hydrochloride for Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of 100mcg/ml Table 3. Major Manufacturers of 200mcg/2ml Table 4. Global Dexmedetomidine Hydrochloride for Injection Market Size Growth Rate by Application (2021-2027) & (K Units) Table 5. Global Dexmedetomidine Hydrochloride for Injection Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 6. Global Dexmedetomidine Hydrochloride for Injection Sales by Regions (2016-2021) & (K Units) Table 7. Global Dexmedetomidine Hydrochloride for Injection Sales Market Share by Regions (2016-2021) Table 8. Global Dexmedetomidine Hydrochloride for Injection Revenue by Regions (2016-2021) & (US$ Million) Table 9. Global Dexmedetomidine Hydrochloride for Injection Sales Forecast by Region (2022-2027) & (K Units) Table 10. Global Dexmedetomidine Hydrochloride for Injection Sales Market Share Forecast by Region (2022-2027) Table 11. Global Dexmedetomidine Hydrochloride for Injection Revenue Forecast by Region (2022-2027) & (US$ Million) Table 12. Global Dexmedetomidine Hydrochloride for Injection Revenue Market Share Forecast by Region (2022-2027) Table 13. Global Dexmedetomidine Hydrochloride for Injection Sales by Manufacturers (2016-2021) (K Units) Table 14. Global Dexmedetomidine Hydrochloride for Injection Sales Share by Manufacturers (2016-2021) Table 15. Ranking of Global Top Dexmedetomidine Hydrochloride for Injection Manufacturers by Revenue (US$ Million) in 2020 Table 16. Dexmedetomidine Hydrochloride for Injection Revenue by Manufacturers (2016-2021) (US$ Million) Table 17. Dexmedetomidine Hydrochloride for Injection Revenue Share by Manufacturers (2016-2021) Table 18. Global Dexmedetomidine Hydrochloride for Injection Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 19. Global Dexmedetomidine Hydrochloride for Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dexmedetomidine Hydrochloride for Injection as of 2020) Table 20. Key Manufacturers Dexmedetomidine Hydrochloride for Injection Price (2016-2021) (US$/Unit) Table 21. Dexmedetomidine Hydrochloride for Injection Manufacturers Manufacturing Base Distribution and Headquarters Table 22. Manufacturers Dexmedetomidine Hydrochloride for Injection Product Type Table 23. Date of International Manufacturers Enter into Dexmedetomidine Hydrochloride for Injection Market Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans Table 25. Global Dexmedetomidine Hydrochloride for Injection Sales by Type (2016-2021) (K Units) Table 26. Global Dexmedetomidine Hydrochloride for Injection Sales Share by Type (2016-2021) Table 27. Global Dexmedetomidine Hydrochloride for Injection Revenue by Type (2016-2021) (US$ Million) Table 28. Global Dexmedetomidine Hydrochloride for Injection Revenue Share by Type (2016-2021) Table 29. Dexmedetomidine Hydrochloride for Injection Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 30. Global Dexmedetomidine Hydrochloride for Injection Sales Forecast by Type (2022-2027) & (K Units) Table 31. Global Dexmedetomidine Hydrochloride for Injection Sales Market Share Forecast by Type (2022-2027) Table 32. Global Dexmedetomidine Hydrochloride for Injection Revenue Forecast V (2022-2027) & (US$ Million) Table 33. Global Dexmedetomidine Hydrochloride for Injection Revenue Market Share Forecast by Type (2022-2027) Table 34. Global Dexmedetomidine Hydrochloride for Injection Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 35. Global Dexmedetomidine Hydrochloride for Injection Sales by Application (2016-2021) (K Units) Table 36. Global Dexmedetomidine Hydrochloride for Injection Sales Share by Application (2016-2021) Table 37. Global Dexmedetomidine Hydrochloride for Injection Revenue by Application (2016-2021) (US$ Million) Table 38. Global Dexmedetomidine Hydrochloride for Injection Revenue Share by Application (2016-2021) Table 39. Dexmedetomidine Hydrochloride for Injection Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 40. Global Dexmedetomidine Hydrochloride for Injection Sales Forecast by Application (2022-2027) & (K Units) Table 41. Global Dexmedetomidine Hydrochloride for Injection Sales Market Share Forecast by Application (2022-2027) Table 42. Global Dexmedetomidine Hydrochloride for Injection Revenue Forecast by Application (2022-2027) & (US$ Million) Table 43. Global Dexmedetomidine Hydrochloride for Injection Revenue Market Share Forecast by Application (2022-2027) Table 44. Global Dexmedetomidine Hydrochloride for Injection Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 45. China Dexmedetomidine Hydrochloride for Injection Sales (K Units) of Key Companies (2016-2021) Table 46. China Dexmedetomidine Hydrochloride for Injection Sales Share by Company (2016-2021) Table 47. China Dexmedetomidine Hydrochloride for Injection Revenue (US$ Million) by Company (2016-2021) Table 48. China Dexmedetomidine Hydrochloride for Injection Revenue Share by Company (2016-2021) Table 49. China Dexmedetomidine Hydrochloride for Injection Sales (K Units) by Type (2016-2021) Table 50. China Dexmedetomidine Hydrochloride for Injection Sales Share by Type (2016-2021) Table 51. China Dexmedetomidine Hydrochloride for Injection Revenue (US$ Million) Market Share by Type (2016-2021) Table 52. China Dexmedetomidine Hydrochloride for Injection Price (US$/Unit) by Type (2016-2021) Table 53. China Dexmedetomidine Hydrochloride for Injection Sales (K Units) by Type (2022-2027) Table 54. China Dexmedetomidine Hydrochloride for Injection Sales Share by Type (2022-2027) Table 55. China Dexmedetomidine Hydrochloride for Injection Revenue (US$ Million) Market Share by Type (2022-2027) Table 56. China Dexmedetomidine Hydrochloride for Injection Revenue Share by Type (2022-2027) Table 57. China Dexmedetomidine Hydrochloride for Injection Price (US$/Unit) by Type (2022-2027) Table 58. China Dexmedetomidine Hydrochloride for Injection Sales (K Units) by Application (2016-2021) Table 59. China Dexmedetomidine Hydrochloride for Injection Sales Share by Application (2016-2021) Table 60. China Dexmedetomidine Hydrochloride for Injection Revenue (US$ Million) Market Share by Application (2016-2021) Table 61. China Dexmedetomidine Hydrochloride for Injection Price (US$/Unit) by Application (2016-2021) Table 62. China Dexmedetomidine Hydrochloride for Injection Sales (K Units) by Application (2022-2027) Table 63. China Dexmedetomidine Hydrochloride for Injection Sales Share by Application (2022-2027) Table 64. China Dexmedetomidine Hydrochloride for Injection Revenue (US$ Million) Market Share by Application (2022-2027) Table 65. China Dexmedetomidine Hydrochloride for Injection Revenue Share by Application (2022-2027) Table 66. China Dexmedetomidine Hydrochloride for Injection Price (US$/Unit) by Application (2022-2027) Table 67. North America Dexmedetomidine Hydrochloride for Injection Sales by Country (2016-2021) & (K Units) Table 68. North America Dexmedetomidine Hydrochloride for Injection Sales Market Share by Country (2016-2021) Table 69. North America Dexmedetomidine Hydrochloride for Injection Revenue by Country (2016-2021) & (US$ Million) Table 70. North America Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Country (2016-2021) Table 71. Asia Pacific Dexmedetomidine Hydrochloride for Injection Sales by Region (2016-2021) & (K Units) Table 72. Asia Pacific Dexmedetomidine Hydrochloride for Injection Sales Market Share by Region (2016-2021) Table 73. Asia Pacific Dexmedetomidine Hydrochloride for Injection Revenue by Region (2016-2021) & (US$ Million) Table 74. Asia Pacific Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Region (2016-2021) Table 75. Europe Dexmedetomidine Hydrochloride for Injection Sales by Country (2016-2021) & (K Units) Table 76. Europe Dexmedetomidine Hydrochloride for Injection Sales Market Share by Country (2016-2021) Table 77. Europe Dexmedetomidine Hydrochloride for Injection Revenue by Country (2016-2021) & (US$ Million) Table 78. Europe Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Country (2016-2021) Table 79. Latin America Dexmedetomidine Hydrochloride for Injection Sales by Country (2016-2021) & (K Units) Table 80. Latin America Dexmedetomidine Hydrochloride for Injection Sales Market Share by Country (2016-2021) Table 81. Latin Americaa Dexmedetomidine Hydrochloride for Injection Revenue by Country (2016-2021) & (US$ Million) Table 82. Latin America Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Country (2016-2021) Table 83. Middle East and Africa Dexmedetomidine Hydrochloride for Injection Sales by Country (2016-2021) & (K Units) Table 84. Middle East and Africa Dexmedetomidine Hydrochloride for Injection Sales Market Share by Country (2016-2021) Table 85. Middle East and Africa Dexmedetomidine Hydrochloride for Injection Revenue by Country (2016-2021) & (US$ Million) Table 86. Middle East and Africa Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Country (2016-2021) Table 87. Pfizer Corporation Information Table 88. Pfizer Description and Business Overview Table 89. Pfizer Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 90. Pfizer Dexmedetomidine Hydrochloride for Injection Product Table 91. Pfizer Recent Development Table 92. Accord Healthcare Corporation Information Table 93. Accord Healthcare Description and Business Overview Table 94. Accord Healthcare Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 95. Accord Healthcare Product Table 96. Accord Healthcare Recent Development Table 97. Akorn Corporation Information Table 98. Akorn Description and Business Overview Table 99. Akorn Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 100. Akorn Product Table 101. Akorn Recent Development Table 102. AuroMedics Corporation Information Table 103. AuroMedics Description and Business Overview Table 104. AuroMedics Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 105. AuroMedics Product Table 106. AuroMedics Recent Development Table 107. Fresenius Kabi Corporation Information Table 108. Fresenius Kabi Description and Business Overview Table 109. Fresenius Kabi Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 110. Fresenius Kabi Product Table 111. Fresenius Kabi Recent Development Table 112. Hikma Corporation Information Table 113. Hikma Description and Business Overview Table 114. Hikma Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 115. Hikma Product Table 116. Hikma Recent Development Table 117. Mylan Corporation Information Table 118. Mylan Description and Business Overview Table 119. Mylan Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 120. Mylan Product Table 121. Mylan Recent Development Table 122. Par Pharmaceuticals Corporation Information Table 123. Par Pharmaceuticals Description and Business Overview Table 124. Par Pharmaceuticals Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 125. Par Pharmaceuticals Product Table 126. Par Pharmaceuticals Recent Development Table 127. Sandoz Corporation Information Table 128. Sandoz Description and Business Overview Table 129. Sandoz Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 130. Sandoz Product Table 131. Sandoz Recent Development Table 132. Sun Pharma Corporation Information Table 133. Sun Pharma Description and Business Overview Table 134. Sun Pharma Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 135. Sun Pharma Product Table 136. Sun Pharma Recent Development Table 137. WG Critical Care Corporation Information Table 138. WG Critical Care Description and Business Overview Table 139. WG Critical Care Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 140. WG Critical Care Product Table 141. WG Critical Care Recent Development Table 142. Athenex Corporation Information Table 143. Athenex Description and Business Overview Table 144. Athenex Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 145. Athenex Product Table 146. Athenex Recent Development Table 147. Cisen Pharmaceutical Corporation Information Table 148. Cisen Pharmaceutical Description and Business Overview Table 149. Cisen Pharmaceutical Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 150. Cisen Pharmaceutical Product Table 151. Cisen Pharmaceutical Recent Development Table 152. Jiangsu Hengrui Pharm Corporation Information Table 153. Jiangsu Hengrui Pharm Description and Business Overview Table 154. Jiangsu Hengrui Pharm Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 155. Jiangsu Hengrui Pharm Product Table 156. Jiangsu Hengrui Pharm Recent Development Table 157. Hunan Kelun Pharmaceutical Corporation Information Table 158. Hunan Kelun Pharmaceutical Description and Business Overview Table 159. Hunan Kelun Pharmaceutical Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 160. Hunan Kelun Pharmaceutical Product Table 161. Hunan Kelun Pharmaceutical Recent Development Table 162. Curegen Pharmaceutical Corporation Information Table 163. Curegen Pharmaceutical Description and Business Overview Table 164. Curegen Pharmaceutical Dexmedetomidine Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 165. Curegen Pharmaceutical Product Table 166. Curegen Pharmaceutical Recent Development Table 167. Dexmedetomidine Hydrochloride for Injection Market Trends Table 168. Dexmedetomidine Hydrochloride for Injection Market Drivers Table 169. Dexmedetomidine Hydrochloride for Injection Market Challenges Table 170. Dexmedetomidine Hydrochloride for Injection Market Restraints Table 171. Dexmedetomidine Hydrochloride for Injection Customers List Table 172. Dexmedetomidine Hydrochloride for Injection Distributors List Table 173. Research Programs/Design for This Report Table 174. Key Data Information from Secondary Sources Table 175. Key Data Information from Primary Sources List of Figures Figure 1. Dexmedetomidine Hydrochloride for Injection Product Picture Figure 2. Global Dexmedetomidine Hydrochloride for Injection Sales Market Share by Type in 2020 & 2027 Figure 3. 100mcg/ml Product Picture Figure 4. 200mcg/2ml Product Picture Figure 5. Global Dexmedetomidine Hydrochloride for Injection Sales Market Share by Application in 2020 & 2027 Figure 6. Hospital Figure 7. Clinics Figure 8. Recovery Center Figure 9. Dexmedetomidine Hydrochloride for Injection Report Years Considered Figure 10. Global Dexmedetomidine Hydrochloride for Injection Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Dexmedetomidine Hydrochloride for Injection Market Size 2016-2027 (US$ Million) Figure 12. Global Dexmedetomidine Hydrochloride for Injection Sales 2016-2027 (K Units) Figure 13. Global Dexmedetomidine Hydrochloride for Injection Market Size Market Share by Region: 2021 Versus 2027 Figure 14. Global Dexmedetomidine Hydrochloride for Injection Sales Market Share by Region (2016-2021) Figure 15. Global Dexmedetomidine Hydrochloride for Injection Sales Market Share by Region in 2020 Figure 16. Global Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Region (2016-2021) Figure 17. Global Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Region in 2020 Figure 18. Global Dexmedetomidine Hydrochloride for Injection Sales Share by Manufacturer in 2020 Figure 19. The Top 10 and 5 Players Market Share by Dexmedetomidine Hydrochloride for Injection Revenue in 2020 Figure 20. Dexmedetomidine Hydrochloride for Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Dexmedetomidine Hydrochloride for Injection Sales Market Share by Type (2016-2021) Figure 22. Global Dexmedetomidine Hydrochloride for Injection Sales Market Share by Type in 2020 Figure 23. Global Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Type (2016-2021) Figure 24. Global Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Type in 2020 Figure 25. Global Dexmedetomidine Hydrochloride for Injection Sales Market Share by Application (2016-2021) Figure 26. Global Dexmedetomidine Hydrochloride for Injection Sales Market Share by Application in 2020 Figure 27. Global Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Application (2016-2021) Figure 28. Global Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Application in 2020 Figure 29. China Dexmedetomidine Hydrochloride for Injection Sales Growth Rate 2016-2027 (K Units) Figure 30. China Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate 2016-2027 (US$ Million) Figure 31. China Dexmedetomidine Hydrochloride for Injection Market Share in Global Market 2016-2027 Figure 32. China 5 and 10 Largest Dexmedetomidine Hydrochloride for Injection Players Market Share by Revenue in Dexmedetomidine Hydrochloride for Injection in 2020 Figure 33. China Dexmedetomidine Hydrochloride for Injection Revenue Share by Type (2016-2021) Figure 34. China Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate by Type in 2016 & 2020 Figure 35. China Dexmedetomidine Hydrochloride for Injection Revenue Share by Application (2016-2021) Figure 36. China Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate by Application in 2016 & 2020 Figure 37. North America Dexmedetomidine Hydrochloride for Injection Sales Growth Rate 2016-2021 (K Units) Figure 38. North America Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 39. North America Dexmedetomidine Hydrochloride for Injection Sales Market Share by Country in 2020 Figure 40. North America Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Country in 2020 Figure 41. U.S. Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 42. U.S. Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Canada Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 44. Canada Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Europe Dexmedetomidine Hydrochloride for Injection Sales Growth Rate 2016-2021 (K Units) Figure 46. Europe Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 47. Europe Dexmedetomidine Hydrochloride for Injection Sales Market Share by Country in 2020 Figure 48. Europe Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Country in 2020 Figure 49. Germany Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 50. Germany Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 51. France Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 52. France Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. U.K. Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 54. U.K. Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. Italy Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 56. Italy Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Russia Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 58. Russia Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Asia Pacific Dexmedetomidine Hydrochloride for Injection Sales Growth Rate 2016-2021 (K Units) Figure 60. Asia Pacific Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 61. Asia Pacific Dexmedetomidine Hydrochloride for Injection Sales Market Share by Region in 2020 Figure 62. Asia Pacific Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Region in 2020 Figure 63. China Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 64. China Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 65. Japan Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 66. Japan Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. South Korea Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 68. South Korea Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. India Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 70. India Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. Australia Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 72. Australia Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Taiwan Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 74. Taiwan Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Indonesia Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 76. Indonesia Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Thailand Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 78. Thailand Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Malaysia Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 80. Malaysia Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Philippines Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 82. Philippines Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Vietnam Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 84. Vietnam Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Latin America Dexmedetomidine Hydrochloride for Injection Sales Growth Rate 2016-2021 (K Units) Figure 86. Latin America Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 87. Latin America Dexmedetomidine Hydrochloride for Injection Sales Market Share by Country in 2020 Figure 88. Latin America Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Country in 2020 Figure 89. Mexico Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 90. Mexico Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 91. Brazil Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 92. Brazil Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Argentina Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 94. Argentina Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Middle East and Africa Dexmedetomidine Hydrochloride for Injection Sales Growth Rate 2016-2021 (K Units) Figure 96. Middle East and Africa Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate 2016-2021 (US$ Million) Figure 97. Middle East and Africa Dexmedetomidine Hydrochloride for Injection Sales Market Share by Country in 2020 Figure 98. Middle East and Africa Dexmedetomidine Hydrochloride for Injection Revenue Market Share by Country in 2020 Figure 99. Turkey Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 100. Turkey Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 101. Saudi Arabia Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 102. Saudi Arabia Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. UAE Dexmedetomidine Hydrochloride for Injection Sales Growth Rate (2016-2021) (K Units) Figure 104. UAE Dexmedetomidine Hydrochloride for Injection Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. Dexmedetomidine Hydrochloride for Injection Value Chain Figure 106. Channels of Distribution Figure 107. Distributors Profiles Figure 108. Bottom-up and Top-down Approaches for This Report Figure 109. Data Triangulation Figure 110. Key Executives Interviewed

Pfizer Accord Healthcare Akorn AuroMedics Fresenius Kabi Hikma Mylan Par Pharmaceuticals Sandoz Sun Pharma WG Critical Care Athenex Cisen Pharmaceutical Jiangsu Hengrui Pharm Hunan Kelun Pharmaceutical Curegen Pharmaceutical